- Home
- XCUR vs NAII Comparison
XCUR vs NAII Comparison
Compare XCUR & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XCUR | NAII |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6M | 21.6M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | XCUR | NAII |
|---|---|---|
| Price | $3.66 | $2.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.3K | ★ 22.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $500,000.00 | ★ $132,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.60 |
| 52 Week Low | $3.10 | $2.33 |
| 52 Week High | $15.87 | $4.96 |
Technical Indicators
Market Signals| Indicator | XCUR | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 37.86 | 34.86 |
| Support Level | $3.47 | $2.64 |
| Resistance Level | $4.23 | $3.43 |
| Average True Range (ATR) | 0.26 | 0.16 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 19.80 | 32.91 |
Price Performance
Historical ComparisonAbout XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.